Page last updated: 2024-12-04

2-keto-4-methylthiobutyric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-keto-4-methylthiobutyric acid: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

4-methylthio-2-oxobutanoic acid : A 2-oxo monocarboxylic acid derived from L-methionine via the action of methionine transaminase. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID473
CHEMBL ID1233860
CHEBI ID33574
SCHEMBL ID126896
MeSH IDM0063320

Synonyms (61)

Synonym
CHEBI:33574 ,
alpha-oxo-gamma-methylthiobutyric acid
286060413u ,
unii-286060413u
CHEMBL1233860
2-oxo-4-methylthio-butanoic acid
LMFA01060170
2-keto-4-methylthiobutyric acid
2-oxo-4-methylthiobutanoate
C01180
583-92-6
4-methylthio-2-oxobutanoic acid
2-oxo-4-methylthiobutanoic acid
KMT ,
4-(methylsulfanyl)-2-oxobutanoic acid
2-oxo-4-thiomethylbutyric acid
DB02238
s-methyl-alpha-ketobutyric acid
alpha-keto-gamma-methiolbutyrate
alpha-ketomethionine
gamma-methiol-keto-butyric acid
4-methylmercapto-2-oxobutyrate
4-methylthio-2-ketobutyric acid
4-(methylthio)-2-oxo-butanoic acid
alpha-oxomethionine
BDBE5218-EF11-4F3E-94DD-6891BAC49A24
butanoic acid, 4-methylthio-2-oxo-
butanoic acid, 4-(methylthio)-2-oxo-
4-methylsulfanyl-2-oxobutanoic acid
2-keto-4-methylthiobutanoic acid
2-ketothiomethylbutyric acid
2-keto-4-thiomethylbutyrate
4-(methylthio)-2-oxobutanoic acid
4-methylthio-2-oxobutyric acid
AKOS006222790
.alpha.-keto-.gamma.-(methylthio)butyric acid
2-keto-4-(methylthio)butyric acid
2-oxo-4-(methylthio)butanoic acid
.alpha.-ketomethionine
butyric acid, .gamma.-methylmercapto-.alpha.-oxo-
4-(methylthio)-2-oxobutyric acid
.alpha.-keto-4-(methylthio)butyric acid
.alpha.-oxo-.gamma.-(methylthio)-n-butyric acid
.alpha.-keto-methylthiobutyric acid
SCHEMBL126896
2-oxo-4-methylthiobutyric acid
4-methylmercapto-2-oxobutyric acid
butyric acid, 4-(methylthio)-2-oxo-
4-(methylsulfanyl)-2-oxobutanoic acid #
SXFSQZDSUWACKX-UHFFFAOYSA-N
4-methylsulfanyl-2-oxo-butanoic acid
bdbm154571
4-methylthio 2-oxobutyric acid (mtob)
DTXSID50207027
4-methylthio-2-ketobutanoic acid
ketomethiobutyric acid
alpha-keto-methiolbutyric acid
keto-4-methylthiobutyrate
Q27093278
EN300-1600874
PD008115
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
omega-(methylthio)-2-oxocarboxylic acidAny 2-oxo monocarboxylic acid in which one of the terminal methyl hydrogens has been replaced by a methylthio group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (14)

PathwayProteinsCompounds
Methionine Metabolism1637
Cystathionine beta-Synthase Deficiency1637
Hypermethioninemia1637
S-Adenosylhomocysteine (SAH) Hydrolase Deficiency1637
Glycine N-Methyltransferase Deficiency1637
Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)1637
Methionine Adenosyltransferase Deficiency1637
Homocystinuria-Megaloblastic Anemia Due to Defect in Cobalamin Metabolism, cblG Complementation Type1637
Methionine Metabolism and Salvage1534
Glucosinolate biosynthesis from methionine049
L-Homomethionine Biosynthesis615
Methionine de novo and salvage pathway148
Yang cycle217
Homomethionine biosynthesis07

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
C-terminal-binding protein 1Homo sapiens (human)Kd2,110.00000.39002.21297.9000AID1801145
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (13)

Processvia Protein(s)Taxonomy
positive regulation of transcription by RNA polymerase IIC-terminal-binding protein 2Homo sapiens (human)
positive regulation of retinoic acid receptor signaling pathwayC-terminal-binding protein 2Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIC-terminal-binding protein 2Homo sapiens (human)
negative regulation of cell population proliferationC-terminal-binding protein 2Homo sapiens (human)
viral genome replicationC-terminal-binding protein 2Homo sapiens (human)
negative regulation of DNA-templated transcriptionC-terminal-binding protein 2Homo sapiens (human)
white fat cell differentiationC-terminal-binding protein 2Homo sapiens (human)
regulation of transcription by RNA polymerase IIC-terminal-binding protein 2Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIC-terminal-binding protein 1Homo sapiens (human)
protein phosphorylationC-terminal-binding protein 1Homo sapiens (human)
negative regulation of cell population proliferationC-terminal-binding protein 1Homo sapiens (human)
viral genome replicationC-terminal-binding protein 1Homo sapiens (human)
negative regulation of DNA-templated transcriptionC-terminal-binding protein 1Homo sapiens (human)
positive regulation of DNA-templated transcriptionC-terminal-binding protein 1Homo sapiens (human)
synaptic vesicle endocytosisC-terminal-binding protein 1Homo sapiens (human)
white fat cell differentiationC-terminal-binding protein 1Homo sapiens (human)
regulation of cell cycleC-terminal-binding protein 1Homo sapiens (human)
synaptic vesicle clusteringC-terminal-binding protein 1Homo sapiens (human)
regulation of transcription by RNA polymerase IIC-terminal-binding protein 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (14)

Processvia Protein(s)Taxonomy
transcription corepressor bindingC-terminal-binding protein 2Homo sapiens (human)
transcription corepressor activityC-terminal-binding protein 2Homo sapiens (human)
protein bindingC-terminal-binding protein 2Homo sapiens (human)
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptorC-terminal-binding protein 2Homo sapiens (human)
protein kinase bindingC-terminal-binding protein 2Homo sapiens (human)
protein-containing complex bindingC-terminal-binding protein 2Homo sapiens (human)
NAD bindingC-terminal-binding protein 2Homo sapiens (human)
DNA-binding transcription factor bindingC-terminal-binding protein 2Homo sapiens (human)
transcription coregulator bindingC-terminal-binding protein 2Homo sapiens (human)
transcription coactivator activityC-terminal-binding protein 2Homo sapiens (human)
transcription corepressor bindingC-terminal-binding protein 1Homo sapiens (human)
chromatin bindingC-terminal-binding protein 1Homo sapiens (human)
transcription corepressor activityC-terminal-binding protein 1Homo sapiens (human)
protein bindingC-terminal-binding protein 1Homo sapiens (human)
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptorC-terminal-binding protein 1Homo sapiens (human)
protein domain specific bindingC-terminal-binding protein 1Homo sapiens (human)
identical protein bindingC-terminal-binding protein 1Homo sapiens (human)
NAD bindingC-terminal-binding protein 1Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingC-terminal-binding protein 1Homo sapiens (human)
DNA-binding transcription factor bindingC-terminal-binding protein 1Homo sapiens (human)
transcription coactivator activityC-terminal-binding protein 1Homo sapiens (human)
transcription coregulator bindingC-terminal-binding protein 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (7)

Processvia Protein(s)Taxonomy
nucleusC-terminal-binding protein 2Homo sapiens (human)
synapseC-terminal-binding protein 2Homo sapiens (human)
transcription repressor complexC-terminal-binding protein 2Homo sapiens (human)
nucleusC-terminal-binding protein 2Homo sapiens (human)
nucleusC-terminal-binding protein 1Homo sapiens (human)
nucleoplasmC-terminal-binding protein 1Homo sapiens (human)
presynaptic active zone cytoplasmic componentC-terminal-binding protein 1Homo sapiens (human)
glutamatergic synapseC-terminal-binding protein 1Homo sapiens (human)
GABA-ergic synapseC-terminal-binding protein 1Homo sapiens (human)
transcription repressor complexC-terminal-binding protein 1Homo sapiens (human)
nucleusC-terminal-binding protein 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1298935Inhibition of CtBP2 (unknown origin) transfected in human HCT116 p53-/- cells assessed as increase in Bik transcription at 2 mM by dual luciferase reporter gene assay relative to control2016Bioorganic & medicinal chemistry, 06-15, Volume: 24, Issue:12
Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP).
AID1298930Inhibition of recombinant His6-tagged CtBP2 (31 to 384 residues) (unknown origin) dehydrogenase activity expressed in Escherichia coli BL21-Codonplus (DE3)-RIL cells using MTOB as substrate after 15 mins by NADH consumption assay2016Bioorganic & medicinal chemistry, 06-15, Volume: 24, Issue:12
Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP).
AID1298931Cytotoxicity against human HCT116 p53-/- cells assessed as inhibition of cell growth after 72 hrs by MTT assay2016Bioorganic & medicinal chemistry, 06-15, Volume: 24, Issue:12
Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP).
AID1298936Inhibition of CtBP2 (unknown origin) transfected in human HCT116 p53-/- cells assessed as increase in Bik transcription at 4 mM by dual luciferase reporter gene assay relative to control2016Bioorganic & medicinal chemistry, 06-15, Volume: 24, Issue:12
Design, synthesis, and biological evaluation of substrate-competitive inhibitors of C-terminal Binding Protein (CtBP).
AID1801145CtBP2 ITC from Article 10.1021/cb500820b: \\Structure-guided design of a high affinity inhibitor to human CtBP.\\2015ACS chemical biology, Apr-17, Volume: 10, Issue:4
Structure-guided design of a high affinity inhibitor to human CtBP.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (102)

TimeframeStudies, This Drug (%)All Drugs %
pre-199050 (49.02)18.7374
1990's19 (18.63)18.2507
2000's15 (14.71)29.6817
2010's17 (16.67)24.3611
2020's1 (0.98)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.60

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.60 (24.57)
Research Supply Index4.74 (2.92)
Research Growth Index4.34 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.60)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (2.65%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other110 (97.35%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]